Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

J&J begins first trial of Covid-19 vaccine after positive preclinical data

pharmaceutical-technologyAugust 03, 2020

Tag: COVID-19 vaccine , Johnson & Johnson , Ad26.COV2.S , clinical trial

PharmaSources Customer Service